These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dermatoscopy of blue vitiligo. Chandrashekar L Clin Exp Dermatol; 2009 Jul; 34(5):e125-6. PubMed ID: 19438538 [TBL] [Abstract][Full Text] [Related]
4. Irritancy of dithranol in normally pigmented and depigmented skin of patients with vitiligo. van de Kerkhof PC; Fokkink HJ Acta Derm Venereol; 1989; 69(3):236-8. PubMed ID: 2566228 [TBL] [Abstract][Full Text] [Related]
5. Paradoxically dark spontaneous repigmentation: a rare complication of generalized vitiligo. Agrawal S; Porto DA; Lim HW J Eur Acad Dermatol Venereol; 2017 May; 31(5):e268-e269. PubMed ID: 27785821 [No Abstract] [Full Text] [Related]
6. Blaschkoid blue vitiligo. Jassi R; Mehta N; Ramam M; Bhari N Int J Dermatol; 2019 Feb; 58(2):e45-e46. PubMed ID: 30456815 [No Abstract] [Full Text] [Related]
7. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas. Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154 [TBL] [Abstract][Full Text] [Related]
8. Dermatitis produced by applications of monobenzone in patients with active vitiligo. Nordlund JJ; Forget B; Kirkwood J; Lerner AB Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053 [TBL] [Abstract][Full Text] [Related]
9. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir. Dogra S; Kumar B Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. Serarslan G; Yönden Z; Söğüt S; Savaş N; Celik E; Arpaci A Clin Exp Dermatol; 2010 Jul; 35(5):487-90. PubMed ID: 19874371 [TBL] [Abstract][Full Text] [Related]
11. [Vulvar melanosis and vitiligo]. Haraszti G; Kemény L; Bónis B; Dobozi A Orv Hetil; 1998 Apr; 139(14):825-8. PubMed ID: 9569730 [TBL] [Abstract][Full Text] [Related]
12. Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus. Park ES; Na JI; Kim SO; Huh CH; Youn SW; Park KC Skin Res Technol; 2006 Nov; 12(4):298-302. PubMed ID: 17026663 [TBL] [Abstract][Full Text] [Related]
14. [Scanning electron microscopy in vitiligo]. Vaisov ASh; Baĭbekov IM; Khoroshaev VA Vestn Dermatol Venerol; 1987; (4):19-20. PubMed ID: 3604441 [No Abstract] [Full Text] [Related]
15. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Vanscheidt W; Hunziker T Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603 [TBL] [Abstract][Full Text] [Related]
16. The possibility of misdiagnosis of generalized vitiligo as pigmentary disease. Cho YH; Lee SJ; Lee HJ; Hann SK; Lee MG; Park YK J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1364-6. PubMed ID: 17062080 [No Abstract] [Full Text] [Related]
17. [Vitiligo-like changes in the skin of workers manufacturing phenol-containing additives]. Telegina KA; Boĭko VI Vestn Dermatol Venerol; 1972 Jan; 46(1):31-4. PubMed ID: 5011889 [No Abstract] [Full Text] [Related]
18. [Dermatology and skin color]. Petit A Soins; 2010 Sep; (748):38-9. PubMed ID: 20963977 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo as an inflammatory skin disorder: a therapeutic perspective. Taïeb A Pigment Cell Melanoma Res; 2012 Jan; 25(1):9-13. PubMed ID: 22099450 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Mulekar SV Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]